Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 Biomarker group BEFREE All compounds were evaluated for their cytotoxic activities against three human cancer cell lines: A375 (melanoma), A549 (lung), and PLC (hepatoma). 29421242 2018
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 Biomarker group BEFREE Selective expression of heparan sulfate (HS) proteoglycans syndecan-1 and perlecan in the AG2 colon cancer-initiating cell line suggests these PGs as potential biomarkers for cancer stem cells. 25715761 2015
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 Biomarker group BEFREE These studies implicate perlecan in cytokine-mediated, innate tissue responses to cancer cell invasion, a process we suggest reflects a modified wound healing tissue response co-opted by prostate cancer cells. 24700612 2014
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 AlteredExpression group BEFREE We demonstrated that macrophages stimulate cancer cell invasion, motility and migration, and that these effects depend on matrix metalloproteinase (MMP) activity and on the activation of epidermal growth factor receptor (EGFR) (at the residue Y(1086)), PLC-γ (phospholipase C-gamma) and Gab1 (GRB2-associated binding protein-1), as evidenced by siRNA (small interference RNA) experiments. 23644655 2014
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 Biomarker group BEFREE Taken together, our results show a previously unidentified tumor suppressor role for this PLC in animal models and, together with observations of marked down-regulation in colorectal, lung, and skin tumors, suggest its use as a biological marker in cancer. 24591640 2014
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 Biomarker group BEFREE Matrix-accumulated PGs, such as versican, perlecan and small leucine-rich PGs, affect cancer cell signaling, growth and survival, cell adhesion, migration and angiogenesis. 20840587 2010
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 Biomarker group BEFREE By more fully understanding perlecan's functioning in angiogenesis, we may gain invaluable insight that could lead to therapeutic interventions in cancer and other pathologic states. 18300285 2008
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 AlteredExpression group BEFREE Among 7 hepatoma cell lines analyzed, 5-alpha-fetoprotein (AFP)-producing hepatoma cell lines (HepG2, Huh7, Hep3B, PLC/PRF/5, and Huh6) were shown to have common gene-expression profiles compared with those of AFP-negative hepatoma cell lines (HLE and SK-Hep1) and cancer cell lines of nonhepatocyte origin (HeLa and KMBC). 11230749 2001
CUI: C1306459
Disease: Primary malignant neoplasm
Primary malignant neoplasm
0.090 Biomarker group BEFREE To test the role of perlecan in malignancy, we generated several stably transfected clones of HT-1080, a human fibrosarcoma cell line, harboring a perlecan cDNA in the antisense orientation. 9187109 1997